1-56500678-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003713.5(PLPP3):c.811-4002T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 152,190 control chromosomes in the GnomAD database, including 1,256 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1256 hom., cov: 32)
Consequence
PLPP3
NM_003713.5 intron
NM_003713.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.293
Publications
30 publications found
Genes affected
PLPP3 (HGNC:9229): (phospholipid phosphatase 3) The protein encoded by this gene is a member of the phosphatidic acid phosphatase (PAP) family. PAPs convert phosphatidic acid to diacylglycerol, and function in de novo synthesis of glycerolipids as well as in receptor-activated signal transduction mediated by phospholipase D. This protein is a membrane glycoprotein localized at the cell plasma membrane. It has been shown to actively hydrolyze extracellular lysophosphatidic acid and short-chain phosphatidic acid. The expression of this gene is found to be enhanced by epidermal growth factor in Hela cells. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLPP3 | ENST00000371250.4 | c.811-4002T>C | intron_variant | Intron 5 of 5 | 1 | NM_003713.5 | ENSP00000360296.3 | |||
ENSG00000284686 | ENST00000642129.1 | n.454-4002T>C | intron_variant | Intron 3 of 5 | ENSP00000492927.1 |
Frequencies
GnomAD3 genomes AF: 0.120 AC: 18193AN: 152072Hom.: 1251 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18193
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.120 AC: 18225AN: 152190Hom.: 1256 Cov.: 32 AF XY: 0.118 AC XY: 8797AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
18225
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
8797
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
8433
AN:
41502
American (AMR)
AF:
AC:
1295
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
318
AN:
3470
East Asian (EAS)
AF:
AC:
147
AN:
5174
South Asian (SAS)
AF:
AC:
326
AN:
4828
European-Finnish (FIN)
AF:
AC:
1162
AN:
10612
Middle Eastern (MID)
AF:
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6152
AN:
68004
Other (OTH)
AF:
AC:
257
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
806
1611
2417
3222
4028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
200
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.